Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | CNR2 | P34972 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
| ▸ | PPARG | P37231 | 1/20 | 0.42 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.41 |
| ▸ | KCNQ3 | O43525 | 1/20 | 0.41 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | RHOC | P08134 | 1/20 | 0.40 |
| ▸ | RHOA | P61586 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | CETP | P11597 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6341025 | 1.00 | SMN1; SMN2 (0.47) | SMN1; SMN2CNR2ATMMAPTALDH1A1 | |
| SCHEMBL6903409 | 0.86 | CNR2 (0.50) | SMN1; SMN2CNR2MAPTALDH1A1KDM4E | |
| SCHEMBL9419902 | 0.80 | CNR1 (0.57) | CNR2MAPTALDH1A1EPHX2KMT2A | |
| SCHEMBL9419871 | 0.79 | MAPT (0.52) | SMN1; SMN2MAPTALDH1A1KDM4EGAA | |
| SCHEMBL9419873 | 0.79 | MAPT (0.52) | SMN1; SMN2MAPTALDH1A1KDM4EGAA | |
| SCHEMBL260379 | 0.78 | SMN1; SMN2 (0.55) | SMN1; SMN2ATMMAPTALDH1A1KMT2A | |
| SCHEMBL260380 | 0.78 | SMN1; SMN2 (0.55) | SMN1; SMN2ATMMAPTALDH1A1KMT2A | |
| SCHEMBL8682896 | 0.73 | LMNA (0.60) | SMN1; SMN2MAPTALDH1A1KDM4EGAA | |
| SCHEMBL8395979 | 0.72 | SMN1; SMN2 (0.48) | SMN1; SMN2ATMMAPTEPHX2KMT2A | |
| SCHEMBL9804687 | 0.72 | SMN1; SMN2 (0.54) | SMN1; SMN2ATMMAPTALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050215597-A1 | Composition for controlling house insect pest and method for controlling house insect pest | ISHIHARA SANGYO KAISHA, LTD (JP) | 2005-09-29 | — | — | US | claimed |
| EP-0500111-A2 | Hydrazone compounds, processes for their production, intermediates useful for their production and pesticidal compositions containing them | ISHIHARA SANGYO KAISHA, LTD. (JP) | 1992-08-26 | — | — | EP | claimed |
| US-5288727-A | Hydrazone compounds, processes for their production, intermediates useful for their production and pesticidal compositions containing them | ISHIHARA SANGYO KAISHA LTD. (JP) | 1994-02-22 | — | — | US | disclosed |
| EP-0500111-A2 | Hydrazone compounds, processes for their production, intermediates useful for their production and pesticidal compositions containing them | ISHIHARA SANGYO KAISHA, LTD. (JP) | 1992-08-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050215597-A1 | Composition for controlling house insect pest and method for controlling house insect pest | DDT, PHB1, ACHE | SMN1; SMN2 2960/4885CNR2 615/4885ATM 3433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.